US Patent Issued to IMMUNE TARGETING on Oct. 14 for "Interleukin 15 fusion proteins, and compositions and therapeutic methods thereof" (Chinese, American Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,781, issued on Oct. 14, was assigned to IMMUNE TARGETING INC. (Dallas).

"Interleukin 15 fusion proteins, and compositions and therapeutic methods thereof" was invented by Yang-Xin Fu (Dallas), Hua Peng (Beijing) and Jingya Guo (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides novel fusion proteins of Interleukin 15 and prodrugs, and compositions and methods of preparation thereof, useful in treating various diseases and disorders (e.g., hyperplasia, solid tumor or hematopoietic malignancy)."

The patent was filed on May 3, 2019, under Application No. 17/051,160.

*For further information, including images, charts and tab...